ABSTRACT: Docusate, a surfactant for the pharmaceutical market, has been demonstrated to be an outstanding solubilizing agent for poorly soluble API’s while providing additional processing benefits in drug formulation. DocuSolv™s are new forms of Docusate which have been developed to overcome handling issues with Docusate. They are granular, free flowing forms of Docusate with fine particle size which dissolve significantly faster and additionally have higher solubility than Docusate itself. This presentation will focus on various forms of Docusate, their characterization and properties.

More Information & Registration